(Reuters) - Eli Lilly launched an ad campaign on Friday ... The ad, asking patients to "be a healthy skeptic", was released soon after a commercial from telehealth firm Hims & Hers', selling ...

Organovo (ONVO) announced the close of the sale of its FXR program, including lead asset FXR314, to Eli Lilly and Company (LLY). The ...

Organovo Holdings Tuesday has completed the sale of its FXR program, including lead asset FXR314, to Eli Lilly and Company (LLY).The transaction, finalized on March 25 ...

Eli Lilly s Pleasant Prairie facility expansion gets final approval, paving the way for a 3 billion Kenosha County investment ...

Eli Lilly is buying a new drug and lowering prices ... which will be paid out "as FXR314 achieves key regulatory and commercial milestones." Lilly will acquire "all commercial and intellectual ...

Eli Lilly launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss drugs in its latest attempt to fend off competition from copies of its weight-loss drug.